<DOC>
	<DOCNO>NCT01235455</DOCNO>
	<brief_summary>This observational survey ass factor influence adherence Betaferon therapy multiple sclerosis patient use element BetaPlus support program , include nurse support auto-injectors . The patient evaluate normal clinical practice ask fill quality life FAMS questionnaire , Coping process ( WCQ ) depression questionnaire CES-D .</brief_summary>
	<brief_title>Portuguese Observational Survey Assess Drug Adherence Patients With Multiple Sclerosis After Conversion Betaferon Using Elements BetaPlus Program - Nurse Support , Auto-injectors</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Multiple Sclerosis , Chronic Progressive</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Relapsingremitting MS ( RRMS ) secondaryprogressive MS ( SPMS ) Previous treatment disease modify drug Adjustment disease modify treatment necessary discretion investigator Switch Betaferon least 1 month longer 3 month prior inclusion Patients fulfil indication local prescribe information Refusal sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Adherence</keyword>
	<keyword>Interferon beta-1b</keyword>
	<keyword>Coping style</keyword>
</DOC>